STOCK TITAN

Marchex (MCHX) completes Archenia acquisition using $10M convertible notes and potential 4M-share earn-out

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Marchex, Inc. completed its acquisition of Archenia, Inc., a performance-based marketing technology company that uses AI, natural-language analytics and automated decisioning to deliver high-intent consumer interactions to advertisers.

As consideration, Marchex issued an aggregate of $10 million in convertible promissory notes to the sellers, including its Chairman and Vice Chairman. The Notes bear 6% interest, are payable in three equal tranches on the 12-, 18- and 24‑month anniversaries of the closing, and are convertible into Class B common stock at $1.80 per share.

Marchex may also issue up to 4 million Class B shares in earn-out consideration, in two blocks of 2 million shares each, if Archenia exceeds prior‑year revenue or Adjusted EBITDA and meets specified integration and customer retention targets in each of the first two 12‑month periods after closing. Stockholders strongly approved the transaction, with approximately 99.9% support under both required vote standards.

Positive

  • None.

Negative

  • None.

Insights

Marchex closes related-party Archenia acquisition using $10M convertible notes and performance-based share earn-outs.

Marchex has acquired 100% of Archenia, adding an AI-driven, performance marketing platform. Consideration consists of $10 million in 6% convertible notes plus up to 4 million Class B shares tied to revenue, Adjusted EBITDA, and integration or retention milestones over two years.

The notes’ $1.80 conversion price and staged maturities spread potential dilution and cash obligations over 24 months. Because key insiders are sellers, the structure and overwhelming approval—about 99.9% under both vote standards—underscore governance steps, including a majority-of-the-minority requirement and detailed pro forma financials.

Future filings with the audited and unaudited Archenia statements and unaudited pro forma information will help investors assess Archenia’s standalone performance and the combined company’s revenue mix, profitability profile, and any leverage or dilution effects from note conversion and contingent share issuance.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.01 Completion of Acquisition or Disposition of Assets Financial
The company completed a significant acquisition or sale of business assets.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Convertible note size $10 million Aggregate principal of notes issued as acquisition consideration
Interest rate on notes 6% Annual interest on Marchex convertible promissory notes
Note payment schedule 3 equal tranches Principal and interest payable at 12-, 18- and 24-month anniversaries
Conversion price $1.80 per share Conversion rate of principal and interest into Class B common stock
Potential earn-out shares per period 2,000,000 shares Class B shares issuable for each of first two 12‑month periods
Total potential earn-out shares 4,000,000 shares Aggregate Class B shares tied to performance and integration targets
Votes for Stock Purchase Proposal 151,454,493 for Overall stockholder vote on transaction approval
Disinterested votes for proposal 32,537,021 for Majority-of-the-minority vote count on Stock Purchase Proposal
convertible promissory notes financial
"the Company issued an aggregate of $10 million in convertible promissory notes issued to the Sellers"
A convertible promissory note is a loan a company takes that can later be turned into shares instead of being paid back in cash; think of lending money now in exchange for a voucher that can become ownership later. Investors care because it mixes credit risk and potential ownership upside—it can protect lenders if a company struggles while also diluting existing shareholders when converted, affecting future share value and investor returns.
Adjusted EBITDA financial
"to the extent (1) Archenia’s revenue or Adjusted EBITDA exceed such amounts for the 12-month period"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Majority of the Minority Vote regulatory
"disregarding stock owned by Russell C. Horowitz and Michael Arends (the “Majority of the Minority Vote”)"
performance-based marketing technology technical
"Archenia is a performance-based marketing technology company focused on customer qualification and acquisition."
unaudited pro forma condensed financial information financial
"Unaudited pro forma financial information of the Company in connection with the Transaction, as set forth in Exhibit 99.3"
events of default financial
"The Notes also include customary events of default, including failure to pay amounts when due"
Events of default are specific breaches or failures listed in a loan, bond, or credit agreement that give lenders the right to act, such as demanding immediate repayment, raising interest rates, or taking secured assets. They matter to investors because triggering one is like setting off a financial alarm: it raises the chance of foreclosure, restructuring, or bankruptcy and can sharply reduce the value of a company’s stock or bonds and increase borrowing costs.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001224133False00012241332026-07-012026-07-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 1, 2026

Marchex, Inc.

(Exact name of Registrant as Specified in its Charter)

 

 

 

Delaware

000-50658

35-2194038

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

 

1448 NW Market St, Suite 500,

Seattle, WA

98107

(Address of principal executive offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (206) 331-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class B Common Stock

 

MCHX

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 1.01 Entry into a Material Definitive Agreement.

The information regarding the Notes (as defined below) set forth in Item 2.01 of this Current Report is incorporated by reference into this Item 1.01.

 

Item 2.01 Completion of Acquisition or Disposition of Assets.

On July 1, 2026 (the “Closing Date”), Marchex, Inc. (the “Company” or “Marchex”) consummated the previously-announced acquisition (the “Transaction”) of 100% of the outstanding shares of capital stock of Archenia, Inc. (“Archenia”) from its stockholders (the “Sellers”), which include Russell C. Horowitz, our Chairman, Michael Arends, our Vice Chairman, and another accredited investor, pursuant to that certain Stock Purchase Agreement, dated May 8, 2026 (the “Stock Purchase Agreement”), by and among the Company and the Sellers. The Stock Purchase Agreement was previously filed as an annex to the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on June 5, 2026 (the “Proxy Statement”).

 

In acquiring 100% of the outstanding shares of capital stock of Archenia, the Company indirectly acquired all of the assets that support Archenia’s business. Archenia is a performance-based marketing technology company focused on customer qualification and acquisition. Archenia transforms consumer intent into AI-verified, outcome-based results by leveraging AI, natural-language analytics, and automated decisioning to identify and deliver high-intent consumer interactions to advertisers.

 

As consideration for the Transaction and pursuant to the Stock Purchase Agreement, on the Closing Date the Company issued an aggregate of $10 million in convertible promissory notes issued to the Sellers (collectively, the “Notes”). The Notes bear interest at 6% and are payable in three equal tranches on the 12-, 18- and 24-month anniversaries of the Closing Date. Principal and interest under the Notes are convertible in whole or in part into shares of Marchex’s Class B common stock at $1.80 per share. The Notes also include customary events of default, including failure to pay amounts when due and certain bankruptcy or insolvency events. Upon an event of default, the outstanding principal and unpaid accrued interest may become immediately due and payable.

 

As additional consideration for the Transaction and pursuant to the Stock Purchase Agreement, for each of the first and second 12-month periods following the Closing Date, to the extent (1) Archenia’s revenue or Adjusted EBITDA exceed such amounts for the 12-month period prior to the Closing Date, and (2) Archenia achieves certain specified integration or customer retention targets, Marchex will issue to the Sellers an aggregate of 2 million shares of its Class B common stock for each such period.

 

The description of the Notes, the Stock Purchase Agreement and the transactions contemplated thereby do not purport to be complete and are qualified in their entirety by reference to the full text of the Notes and the Stock Purchase Agreement, which are filed as exhibits hereto and incorporated by reference herein.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information regarding the direct financial obligations created by the Notes set forth in Item 2.01 of this Current Report is incorporated by reference into this Item 2.03.

 

Item 3.02 Unregistered Sale of Equity Securities.

The information regarding the sale of the Notes to the Sellers set forth in Item 2.01 of this Current Report is incorporated by reference into this Item 3.02.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

Special Meeting of Stockholders

 

On July 1, 2026, Marchex held a special meeting (the “Special Meeting”) of stockholders at which the following proposals were submitted: (1) the approval of the proposal to approve the Transaction, the Stock Purchase Agreement and the Related Agreements as described in the Proxy Statement (the “Stock Purchase Proposal”), and (2) the approval of the adjournment or postponement of the Special Meeting to a later date, if necessary or appropriate, to allow for the solicitation of additional proxies in favor of the Stock Purchase Proposal (the “Adjournment Proposal”).

 

 

The final results for each of the matters submitted to a vote of stockholders at the Special Meeting, as certified by Computershare, the inspector of elections for the Special Meeting, are as follows:

 

Class A & Class B Votes

For

Against

Abstain

Non-Votes

 


 

Proposal 1 - Stock Purchase Proposal

151,454,493

 

25,074

 

306

 

0

Proposal 2 - Adjournment Proposal

151,316,417

 

163,150

 

306

 

0

 

 

Disinterested Class A & Class B Votes

For

Against

Abstain

Non-Votes

Proposal 1 – Stock Purchase Proposal

32,537,021

 

25,074

 

306

 

0

Proposal 2 - Adjournment Proposal

32,398,945

 

163,150

 

306

 

0

 

The Stock Purchase Proposal required the approval of (a) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class) (the “Simple Majority Vote”) and (b) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends (the “Majority of the Minority Vote”), in each case as of the close of business on the record date and present or represented by proxy at the Special Meeting. The Stock Purchase Proposal was approved by approximately 99.9% under the Simple Majority Vote and approximately 99.9% under the Majority of the Minority Vote.

 

Item 9.01 Financial Statements and Exhibits.

(a) Financial statements of businesses acquired.

 

Audited financial statements of Archenia and its subsidiary as of and for the year ended December 31, 2025, as set forth in Exhibit 99.1 to this Current Report, are included as an exhibit to this Current Report and incorporated by reference into this Item 9.01.

 

Unaudited financial statements of Archenia and its subsidiary as of and for the quarterly period ended March 31, 2026, as set forth in Exhibit 99.2 to this Current Report, are included as an exhibit to this Current Report and incorporated by reference into this Item 9.01.

 

 

(b) Pro forma financial information.

 

Unaudited pro forma financial information of the Company in connection with the Transaction, as set forth in Exhibit 99.3 to this Current Report, is included as an exhibit to this Current Report and incorporated by reference into this Item 9.01

 

(d) Exhibits.

 

The following exhibits are filed herewith or incorporated by reference:

 

Exhibit No.

Description

 

 

2.1*

Stock Purchase Agreement, dated May 8, 2026, between the Company and the Sellers (incorporated by reference to Annex A of the Proxy Statement, as filed with the SEC on June 5, 2026).

 

 

 

4.1

 

Form of Convertible Promissory Note.

 

 

 

99.1*

 

Audited Financial Statements of Archenia, Inc. and Subsidiary (incorporated by reference to the section titled “Audited Financial Statements of Archenia, Inc. and Subsidiary” beginning on page F-7 of the Proxy Statement, as filed with the SEC on June 5, 2026).

 

 

 

99.2*

 

Unaudited Financial Statements of Archenia, Inc. and Subsidiary (incorporated by reference to the section titled “Unaudited Financial Statements of Archenia, Inc. and Subsidiary” beginning on page F-23 of the Proxy Statement, as filed with the SEC on June 5, 2026).

 

 

 

99.3*

 

Unaudited Pro Forma Condensed Financial Information of the Company (incorporated by reference to the section titled “Unaudited Pro Forma Condensed Financial Information” beginning on page F-2 of the Proxy Statement, as filed with the SEC on June 5, 2026).

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Previously filed

 


 

Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

MARCHEX, INC.

 

 

Date: July 1, 2026

By:

/s/ FRANCIS J. FEENEY

 

Name:

Francis J. Feeney

 

Title:

Corporate Secretary

 

 


FAQ

What transaction did Marchex (MCHX) complete with Archenia?

Marchex completed its acquisition of 100% of Archenia’s outstanding capital stock, indirectly acquiring all assets supporting Archenia’s performance-based marketing technology business. Archenia focuses on AI-driven customer qualification, turning consumer intent into outcome-based results for advertisers using natural-language analytics and automated decisioning.

How is Marchex paying for the Archenia acquisition?

Marchex issued an aggregate of $10 million in convertible promissory notes to the Archenia sellers, bearing 6% interest and payable in three equal tranches. Principal and interest are convertible into Marchex Class B common stock at $1.80 per share, spreading cash and dilution impacts over time.

What additional share-based earn-out could Archenia’s sellers receive from Marchex (MCHX)?

For each of the first and second 12‑month periods after closing, Archenia’s sellers may receive 2 million Class B shares if revenue or Adjusted EBITDA exceed pre-closing levels and specified integration or customer retention targets are achieved, for a total potential 4 million additional shares.

What are the key terms of Marchex’s $10 million convertible notes issued for Archenia?

The notes total $10 million, bear 6% interest, and are payable in three equal tranches on the 12-, 18- and 24‑month anniversaries of closing. Principal and interest can convert into Marchex Class B stock at $1.80 per share, with customary default and acceleration provisions.

How did Marchex (MCHX) stockholders vote on the Archenia transaction?

Stockholders approved the stock purchase proposal by approximately 99.9% under both the simple majority vote and the majority-of-the-minority vote standards. Separate tallies were taken excluding shares owned by Russell C. Horowitz and Michael Arends to satisfy the minority approval requirement.

What financial information about Archenia and the combined company will be available to Marchex investors?

Audited Archenia financial statements for the year ended December 31, 2025, unaudited statements for the quarter ended March 31, 2026, and unaudited pro forma condensed financial information for Marchex related to the transaction are being provided as exhibits, offering detailed views of Archenia and the combined entity.

Filing Exhibits & Attachments

2 documents